Chat with us, powered by LiveChat

Loading...

Animal Antibiotics And Antimicrobials Market Report

RA01955

Animal Antibiotics and Antimicrobials Market, by Product (Tetracycline, Penicillin, Sulfonamide, Macrolide, Cephalosporin, Fluoroquinolone), Animal Type (Food-producing Animals, Companion Animals), Mode Of Delivery (Premixes, Oral Powder, Injection), Animal (Food-producing & Companion): Global Opportunity Analysis and Industry Forecast, 2020-2027

RA01955

Pages: NA

Jan 2021

The research report offers a comprehensive analysis of the global animal antibiotics and antimicrobials market with thorough study of various facets of the market such as market dynamics, key segments, major regions, prominent players, and competitive landscape.

The report offers a clearer picture of the current market scenario and future trends of the global animal antibiotics and antimicrobials market based on impact of several market dynamics and vital forces impelling the market. The market dynamics acknowledges the drivers and opportunities that are the major contributors for the global animal antibiotics and antimicrobials market growth. Moreover, the report includes restraints and challenges that hold potential to hinder the market growth. Furthermore, the report delivers Porter’s five forces analysis, which specifically highlights the effects of key forces on the global animal antibiotics and antimicrobials market.

The report provides the global animal antibiotics and antimicrobials market size and estimations, which are analyzed through various segments. Besides, the regional market analysis of these segments is included in the report. Each segment evoked in the report is studied at regional as well as country level to provide broad coverage of global animal antibiotics and antimicrobials market. The report divides the global animal antibiotics and antimicrobials market into four major regions or geographies including North America, Europe, Asia-Pacific, and LAMEA. These regions are further sub-divided into countries to cover animal antibiotics and antimicrobials market landscape across respective regions.

Additionally, the competitive scenario of the global animal antibiotics and antimicrobials market is covered in the report. The report further studies the major players operating in the global animal antibiotics and antimicrobials market to understand their competitive strengths and current position in the market. The report outlines 10 key companies. Also, the company profiles covered in the report include various data-points such as company overview, financial performance, company executives, major growth strategies adopted by company, new advancements and initiatives by the company to sustain and strengthen their position in the global animal antibiotics and antimicrobials market, and others.

Research Methodology

We at Research Dive offer our clients complete research and analysis based on a wide-ranging variety of factual inputs, which typically includes regional acumen, reliable statistics, and interviews of industry participants. An impactful role is played by the in-house market experts to design analytic models and tools that are personalized to the requirements of an industry segment. These analytical models & tools sterilize the data & statistics and enhance the accuracy of our recommendations and advice.

For completion of this research study, interviews and long hours of discussions have been conducted with a broad range of stakeholders including upstream as well as downstream participants. A number of annual reports, product type literatures, industry releases, and other associated documents of major industry contributors have been analyzed & reviewed to get a broader and better understanding of the market. We at Research Dive have effected a mix of primary and secondary research for the market forecasts and estimations. The initial phase of our detailed research report is formulated by secondary research, where we conduct data mining at a broader range by referring to certified data sources such as independent studies, technical journals, trade association’s releases, medical journals, and materials published by regulatory, and government authorities.

KEY MARKET BENEFITS

  • The report offers market size and estimation for the forecast period from 2020 to 2027
  • The report highlights recent trends, new developments, innovations, and qualitative & quantitative analysis of the animal antibiotics and antimicrobials market over the forecast period
  • This report provides the prevailing and forthcoming opportunities along with the strategic assessment of the global animal antibiotics and antimicrobials market growth
  • The market size and estimations entailed in the report are based on a comprehensive analysis of market drivers, challenges, restraints, and key innovations in the animal antibiotics and antimicrobials market
  • The report offers information on leading market players, top winning business strategies, and Porter’s Five Analysis
  • The initiatives and development plans undertaken by government bodies and the top market players are included in the report to understand the competitive scenario of the global animal antibiotics and antimicrobials market

KEY MARKET SEGMENTS

The report segments the global market into product ,animal type ,mode of delivery .

  • Product: Tetracycline, Penicillin, Sulfonamide, Macrolide, Cephalosporin, Fluoroquinolone
  • Animal Type: Food-producing Animals, Companion Animals
  • Mode Of Delivery: Premixes, Oral Powder, Injection), Animal (Food-producing & Companion

Geographically, the report evaluates the global market across North America, Europe, Asia Pacific, and LAMEA.

  • The North American countries explored in the report are the U.S., Canada, and Mexico
  • The European countries explored in the report are Germany, the U.K., France, Spain, Italy, and Rest of Europe
  • The Asian countries explored in the report are Japan, China, India, Australia, and Rest of Asia-Pacific
  • The countries in LAMEA explored in the report are Brazil, Saudi Arabia, South Africa, South Korea, and Rest of LAMEA

KEY MARKET PLAYERS

The report covers the leading players operating in the global animal antibiotics and antimicrobials market that focus on geographical expansion and advancements & innovations to obtain a competitive edge in the global market space. The prominent players enlisted in the report include Merck & Co., Inc., Dechra Pharmaceuticals PLC, Zoetis, Inc., Zoetis, Inc. …., and others.

The report summarizes various aspects of all these key players that include the following:

    1. Zoetis, Inc.

    2. Merck & Co., Inc.

    3. Eli Lilly and Company.

    4. Bayer AG.

    5. Virbac .

    6. Boehringer Ingelheim GmbH .

    7. Sanofi .

    8. Ceva Sante Animale .

    9. Vetoquinol S.A. .

    10. Dechra Pharmaceuticals PLC

  • 1. RESEARCH METHODOLOGY

    • 1.1. Desk Research

    • 1.2. Real time insights and validation

    • 1.3. Forecast model

    • 1.4. Assumptions and forecast parameters

    • 1.5. Market size estimation

      • 1.5.1. Top-down approach

      • 1.5.2. Bottom-up approach

  • 2. REPORT SCOPE

    • 2.1. Market definition

    • 2.2. Key objectives of the study

    • 2.3. Report overview

    • 2.4. Market segmentation

    • 2.5. Overview of the impact of COVID-19 on Global Animal Antibiotics and Antimicrobials Market

  • 3. EXECUTIVE SUMMARY

  • 4. MARKET OVERVIEW

    • 4.1. Introduction

    • 4.2. Growth impact forces

      • 4.2.1. Drivers

      • 4.2.2. Restraints

      • 4.2.3. Opportunities

    • 4.3. Market value chain analysis

      • 4.3.1. List of raw material suppliers

      • 4.3.2. List of manufacturers

      • 4.3.3. List of distributors

    • 4.4. Innovation & sustainability matrices

      • 4.4.1. Technology matrix

      • 4.4.2. Regulatory matrix

    • 4.5. Porter’s five forces analysis

      • 4.5.1. Bargaining power of suppliers

      • 4.5.2. Bargaining power of consumers

      • 4.5.3. Threat of substitutes

      • 4.5.4. Threat of new entrants

      • 4.5.5. Competitive rivalry intensity

    • 4.6. PESTLE analysis

      • 4.6.1. Political

      • 4.6.2. Economical

      • 4.6.3. Social

      • 4.6.4. Technological

      • 4.6.5. Environmental

    • 4.7. Impact of COVID-19 on Animal Antibiotics and Antimicrobials Market

      • 4.7.1. Pre-covid market scenario

      • 4.7.2. Post-covid market scenario

  • 5. Animal Antibiotics And Antimicrobials Market, By Product

    • 5.1. Overview

    • 5.2 Tetracycline

      • 5.2.1 Definition, key trends, growth factors, and opportunities

      • 5.2.2 Market size analysis, by region, 2020-2027

      • 5.2.3 Market share analysis, by country, 2020-2027

    • 5.3 Penicillin

      • 5.3.1 Definition, key trends, growth factors, and opportunities

      • 5.3.2 Market size analysis, by region, 2020-2027

      • 5.3.3 Market share analysis, by country, 2020-2027

    • 5.4 Sulfonamide

      • 5.4.1 Definition, key trends, growth factors, and opportunities

      • 5.4.2 Market size analysis, by region, 2020-2027

      • 5.4.3 Market share analysis, by country, 2020-2027

    • 5.5 Macrolide

      • 5.5.1 Definition, key trends, growth factors, and opportunities

      • 5.5.2 Market size analysis, by region, 2020-2027

      • 5.5.3 Market share analysis, by country, 2020-2027

    • 5.6 Cephalosporin

      • 5.6.1 Definition, key trends, growth factors, and opportunities

      • 5.6.2 Market size analysis, by region, 2020-2027

      • 5.6.3 Market share analysis, by country, 2020-2027

    • 5.7 Fluoroquinolone

      • 5.7.1 Definition, key trends, growth factors, and opportunities

      • 5.7.2 Market size analysis, by region, 2020-2027

      • 5.7.3 Market share analysis, by country, 2020-2027

    • 5.8 Research Dive Exclusive Insights

      • 5.8.1 Market attractiveness

      • 5.8.2 Competition heatmap

  • 6. Animal Antibiotics And Antimicrobials Market, By Cell Source

    • 6.1. Overview

    • 6.2 Food-producing Animals

      • 6.2.1 Definition, key trends, growth factors, and opportunities

      • 6.2.2 Market size analysis, by region, 2020-2027

      • 6.2.3 Market share analysis, by country, 2020-2027

    • 6.3 Companion Animals

      • 6.3.1 Definition, key trends, growth factors, and opportunities

      • 6.3.2 Market size analysis, by region, 2020-2027

      • 6.3.3 Market share analysis, by country, 2020-2027

    • 6.4 Research Dive Exclusive Insights

      • 6.4.1 Market attractiveness

      • 6.4.2 Competition heatmap

  • 7. Animal Antibiotics And Antimicrobials Market, By Wound Type

    • 7.1. Overview

    • 7.2 Premixes, Oral Powder, Injection), Animal (Food-producing & Companion

      • 7.2.1 Definition, key trends, growth factors, and opportunities

      • 7.2.2 Market size analysis, by region, 2020-2027

      • 7.2.3 Market share analysis, by country, 2020-2027

    • 7.3 Research Dive Exclusive Insights

      • 7.3.1 Market attractiveness

      • 7.3.2 Competition heatmap

  • 8. Animal Antibiotics And Antimicrobials Market, By Region

    • 8.1 North America

      • 8.1.1 U.S

        • 8.1.1.1 Market size analysis, By Product, 2020-2027

        • 8.1.1.2 Market size analysis, By Cell Source, 2020-2027

        • 8.1.1.3 Market size analysis, By Wound Type, 2020-2027

      • 8.1.2 Canada

        • 8.1.2.1 Market size analysis, By Product, 2020-2027

        • 8.1.2.2 Market size analysis, By Cell Source, 2020-2027

        • 8.1.2.3 Market size analysis, By Wound Type, 2020-2027

      • 8.1.3 Mexico

        • 8.1.3.1 Market size analysis, By Product, 2020-2027

        • 8.1.3.2 Market size analysis, By Cell Source, 2020-2027

        • 8.1.3.3 Market size analysis, By Wound Type, 2020-2027

      • 8.1.4 Research Dive Exclusive Insights

        • 8.1.4.1 Market attractiveness

        • 8.1.4.2 Competition heatmap

    • 8.2 Europe

      • 8.2.1 Germany

        • 8.2.1.1 Market size analysis, By Product, 2020-2027

        • 8.2.1.2 Market size analysis, By Cell Source, 2020-2027

        • 8.2.1.3 Market size analysis, By Wound Type, 2020-2027

      • 8.2.2 UK

        • 8.2.2.1 Market size analysis, By Product, 2020-2027

        • 8.2.2.2 Market size analysis, By Cell Source, 2020-2027

        • 8.2.2.3 Market size analysis, By Wound Type, 2020-2027

      • 8.2.3 France

        • 8.2.3.1 Market size analysis, By Product, 2020-2027

        • 8.2.3.2 Market size analysis, By Cell Source, 2020-2027

        • 8.2.3.3 Market size analysis, By Wound Type, 2020-2027

      • 8.2.4 Spain

        • 8.2.4.1 Market size analysis, By Product, 2020-2027

        • 8.2.4.2 Market size analysis, By Cell Source, 2020-2027

        • 8.2.4.3 Market size analysis, By Wound Type, 2020-2027

      • 8.2.5 Italy

        • 8.2.5.1 Market size analysis, By Product, 2020-2027

        • 8.2.5.2 Market size analysis, By Cell Source, 2020-2027

        • 8.2.5.3 Market size analysis, By Wound Type, 2020-2027

      • 8.2.6 Rest of Europe

        • 8.2.6.1 Market size analysis, By Product, 2020-2027

        • 8.2.6.2 Market size analysis, By Cell Source, 2020-2027

        • 8.2.6.3 Market size analysis, By Wound Type, 2020-2027

      • 8.2.7 Research Dive Exclusive Insights

        • 8.2.7.1 Market attractiveness

        • 8.2.7.2 Competition heatmap

    • 8.3 Asia-Pacific

      • 8.3.1 China

        • 8.3.1.1 Market size analysis, By Product, 2020-2027

        • 8.3.1.2 Market size analysis, By Cell Source, 2020-2027

        • 8.3.1.3 Market size analysis, By Wound Type, 2020-2027

      • 8.3.2 Japan

        • 8.3.2.1 Market size analysis, By Product, 2020-2027

        • 8.3.2.2 Market size analysis, By Cell Source, 2020-2027

        • 8.3.2.3 Market size analysis, By Wound Type, 2020-2027

      • 8.3.3 India

        • 8.3.3.1 Market size analysis, By Product, 2020-2027

        • 8.3.3.2 Market size analysis, By Cell Source, 2020-2027

        • 8.3.3.3 Market size analysis, By Wound Type, 2020-2027

      • 8.3.4 Australia

        • 8.3.4.1 Market size analysis, By Product, 2020-2027

        • 8.3.4.2 Market size analysis, By Cell Source, 2020-2027

        • 8.3.4.3 Market size analysis, By Wound Type, 2020-2027

      • 8.3.5 South Korea

        • 8.3.5.1 Market size analysis, By Product, 2020-2027

        • 8.3.5.2 Market size analysis, By Cell Source, 2020-2027

        • 8.3.5.3 Market size analysis, By Wound Type, 2020-2027

      • 8.3.6 Rest of Asia-Pacific

        • 8.3.6.1 Market size analysis, By Product, 2020-2027

        • 8.3.6.2 Market size analysis, By Cell Source, 2020-2027

        • 8.3.6.3 Market size analysis, By Wound Type, 2020-2027

      • 8.3.7 Research Dive Exclusive Insights

        • 8.3.7.1 Market attractiveness

        • 8.3.7.2 Competition heatmap

    • 8.4 LAMEA

      • 8.4.1 Brazil

        • 8.4.1.1 Market size analysis, By Product, 2020-2027

        • 8.4.1.2 Market size analysis, By Cell Source, 2020-2027

        • 8.4.1.3 Market size analysis, By Wound Type, 2020-2027

      • 8.4.2 Saudi Arabia

        • 8.4.2.1 Market size analysis, By Product, 2020-2027

        • 8.4.2.2 Market size analysis, By Cell Source, 2020-2027

        • 8.4.2.3 Market size analysis, By Wound Type, 2020-2027

      • 8.4.3 UAE

        • 8.4.3.1 Market size analysis, By Product, 2020-2027

        • 8.4.3.2 Market size analysis, By Cell Source, 2020-2027

        • 8.4.3.3 Market size analysis, By Wound Type, 2020-2027

      • 8.4.4 South Africa

        • 8.4.4.1 Market size analysis, By Product, 2020-2027

        • 8.4.4.2 Market size analysis, By Cell Source, 2020-2027

        • 8.4.4.3 Market size analysis, By Wound Type, 2020-2027

      • 8.4.5 Rest of LAMEA

        • 8.4.5.1 Market size analysis, By Product, 2020-2027

        • 8.4.5.2 Market size analysis, By Cell Source, 2020-2027

        • 8.4.5.3 Market size analysis, By Wound Type, 2020-2027

      • 8.4.6 Research Dive Exclusive Insights

        • 8.4.6.1 Market attractiveness

        • 8.4.6.2 Competition heatmap

  • 9. Competitive Landscape

    • 9.1 Top winning strategies, 2020-2027

      • 9.1.1 By strategy

      • 9.1.2 By year

    • 9.2 Strategic overview

    • 9.3 Market share analysis, 2020-2027

  • 10. Company Profiles

    • 10.1 Zoetis, Inc.

      • 10.1.1 Overview

      • 10.1.2 Business segments

      • 10.1.3 Product portfolio

      • 10.1.4 Financial performance

      • 10.1.5 Recent developments

      • 10.1.6 SWOT analysis

    • 10.2 Merck & Co., Inc.

      • 10.2.1 Overview

      • 10.2.2 Business segments

      • 10.2.3 Product portfolio

      • 10.2.4 Financial performance

      • 10.2.5 Recent developments

      • 10.2.6 SWOT analysis

    • 10.3 Eli Lilly and Company.

      • 10.3.1 Overview

      • 10.3.2 Business segments

      • 10.3.3 Product portfolio

      • 10.3.4 Financial performance

      • 10.3.5 Recent developments

      • 10.3.6 SWOT analysis

    • 10.4 Bayer AG.

      • 10.4.1 Overview

      • 10.4.2 Business segments

      • 10.4.3 Product portfolio

      • 10.4.4 Financial performance

      • 10.4.5 Recent developments

      • 10.4.6 SWOT analysis

    • 10.5 Virbac .

      • 10.5.1 Overview

      • 10.5.2 Business segments

      • 10.5.3 Product portfolio

      • 10.5.4 Financial performance

      • 10.5.5 Recent developments

      • 10.5.6 SWOT analysis

    • 10.6 Boehringer Ingelheim GmbH .

      • 10.6.1 Overview

      • 10.6.2 Business segments

      • 10.6.3 Product portfolio

      • 10.6.4 Financial performance

      • 10.6.5 Recent developments

      • 10.6.6 SWOT analysis

    • 10.7 Sanofi .

      • 10.7.1 Overview

      • 10.7.2 Business segments

      • 10.7.3 Product portfolio

      • 10.7.4 Financial performance

      • 10.7.5 Recent developments

      • 10.7.6 SWOT analysis

    • 10.8 Ceva Sante Animale .

      • 10.8.1 Overview

      • 10.8.2 Business segments

      • 10.8.3 Product portfolio

      • 10.8.4 Financial performance

      • 10.8.5 Recent developments

      • 10.8.6 SWOT analysis

    • 10.9 Vetoquinol S.A. .

      • 10.9.1 Overview

      • 10.9.2 Business segments

      • 10.9.3 Product portfolio

      • 10.9.4 Financial performance

      • 10.9.5 Recent developments

      • 10.9.6 SWOT analysis

    • 10.10 Dechra Pharmaceuticals PLC

      • 10.10.1 Overview

      • 10.10.2 Business segments

      • 10.10.3 Product portfolio

      • 10.10.4 Financial performance

      • 10.10.5 Recent developments

      • 10.10.6 SWOT analysis

Research Methodology

Purchase Options

Personalize this research

  • Triangulate with your own data
  • Request your format and definition
  • Get a deeper dive on a specific application, geography, customer or competitor
10% Off on Customization
Contact Us

Customers Also Viewed